Free Trial

Aflac (AFL) Competitors

Aflac logo
$111.32 +1.64 (+1.50%)
(As of 11/15/2024 ET)

AFL vs. MET, PRU, HUM, CNC, UNM, PRI, LNC, CNO, OSCR, and CIA

Should you be buying Aflac stock or one of its competitors? The main competitors of Aflac include MetLife (MET), Prudential Financial (PRU), Humana (HUM), Centene (CNC), Unum Group (UNM), Primerica (PRI), Lincoln National (LNC), CNO Financial Group (CNO), Oscar Health (OSCR), and Citizens (CIA).

Aflac vs.

MetLife (NYSE:MET) and Aflac (NYSE:AFL) are both large-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, community ranking, valuation, media sentiment, analyst recommendations, dividends and earnings.

89.8% of MetLife shares are owned by institutional investors. Comparatively, 67.4% of Aflac shares are owned by institutional investors. 0.3% of MetLife shares are owned by company insiders. Comparatively, 0.9% of Aflac shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Aflac has a net margin of 22.02% compared to MetLife's net margin of 5.27%. MetLife's return on equity of 20.01% beat Aflac's return on equity.

Company Net Margins Return on Equity Return on Assets
MetLife5.27% 20.01% 0.86%
Aflac 22.02%16.34%3.15%

Aflac has lower revenue, but higher earnings than MetLife. Aflac is trading at a lower price-to-earnings ratio than MetLife, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MetLife$66.91B0.86$1.58B$4.9616.80
Aflac$18.70B3.31$4.66B$6.6416.77

MetLife pays an annual dividend of $2.18 per share and has a dividend yield of 2.6%. Aflac pays an annual dividend of $2.00 per share and has a dividend yield of 1.8%. MetLife pays out 44.0% of its earnings in the form of a dividend. Aflac pays out 30.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. MetLife has raised its dividend for 11 consecutive years and Aflac has raised its dividend for 43 consecutive years.

MetLife has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500. Comparatively, Aflac has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500.

In the previous week, MetLife had 9 more articles in the media than Aflac. MarketBeat recorded 28 mentions for MetLife and 19 mentions for Aflac. Aflac's average media sentiment score of 1.07 beat MetLife's score of 0.70 indicating that Aflac is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MetLife
15 Very Positive mention(s)
1 Positive mention(s)
10 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Aflac
12 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

MetLife received 369 more outperform votes than Aflac when rated by MarketBeat users. Likewise, 73.79% of users gave MetLife an outperform vote while only 56.74% of users gave Aflac an outperform vote.

CompanyUnderperformOutperform
MetLifeOutperform Votes
946
73.79%
Underperform Votes
336
26.21%
AflacOutperform Votes
577
56.74%
Underperform Votes
440
43.26%

MetLife presently has a consensus price target of $88.46, indicating a potential upside of 6.16%. Aflac has a consensus price target of $97.93, indicating a potential downside of 12.03%. Given MetLife's stronger consensus rating and higher probable upside, equities research analysts plainly believe MetLife is more favorable than Aflac.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MetLife
0 Sell rating(s)
0 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
3.00
Aflac
3 Sell rating(s)
9 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

MetLife beats Aflac on 12 of the 21 factors compared between the two stocks.

Get Aflac News Delivered to You Automatically

Sign up to receive the latest news and ratings for AFL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AFL vs. The Competition

MetricAflacAccident & health insurance IndustryFinance SectorNYSE Exchange
Market Cap$61.84B$24.76B$11.00B$19.82B
Dividend Yield1.81%2.28%5.94%3.50%
P/E Ratio16.7710.1028.4842.29
Price / Sales3.311.6845.0420.83
Price / Cash14.1911.5118.4921.65
Price / Book2.491.743.694.66
Net Income$4.66B$1.71B$998.34M$983.45M
7 Day Performance2.82%1.98%-0.06%-2.12%
1 Month Performance-3.21%2.45%1.86%-0.39%
1 Year Performance36.14%35.98%24.78%23.34%

Aflac Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AFL
Aflac
4.5752 of 5 stars
$111.32
+1.5%
$97.93
-12.0%
+37.2%$61.84B$18.70B16.7712,785Short Interest ↓
Positive News
MET
MetLife
4.9741 of 5 stars
$82.60
+0.7%
N/A+34.3%$57.19B$66.91B16.6545,000Analyst Upgrade
Short Interest ↓
News Coverage
PRU
Prudential Financial
4.968 of 5 stars
$125.75
+0.4%
N/A+34.6%$44.77B$50.89B11.1840,658Analyst Upgrade
News Coverage
HUM
Humana
4.7013 of 5 stars
$282.97
-2.2%
N/A-46.3%$34.07B$115.01B25.0667,600Short Interest ↑
Analyst Revision
CNC
Centene
4.9686 of 5 stars
$58.69
+1.1%
N/A-21.5%$29.63B$154.00B10.1967,700Insider Buying
Short Interest ↑
Analyst Revision
UNM
Unum Group
4.8582 of 5 stars
$72.26
+1.7%
N/A+73.9%$13.20B$12.39B7.8210,812Analyst Upgrade
Insider Selling
Analyst Revision
News Coverage
PRI
Primerica
4.6829 of 5 stars
$296.82
-1.1%
N/A+46.3%$9.90B$2.82B22.683,450Analyst Downgrade
Insider Selling
Buyback Announcement
Short Interest ↓
News Coverage
LNC
Lincoln National
4.9093 of 5 stars
$34.92
-0.3%
N/A+51.7%$5.95B$13.63B24.9411,024Dividend Announcement
CNO
CNO Financial Group
4.2249 of 5 stars
$39.05
-0.5%
N/A+55.3%$4.03B$4.15B15.753,500Dividend Announcement
Insider Selling
Short Interest ↑
News Coverage
OSCR
Oscar Health
3.5003 of 5 stars
$15.45
+14.6%
N/A+108.0%$3.74B$5.86B-257.462,400Insider Buying
News Coverage
Gap Up
High Trading Volume
CIA
Citizens
1.0484 of 5 stars
$4.52
+3.0%
N/A+38.9%$225.41M$240.68M10.51220

Related Companies and Tools


This page (NYSE:AFL) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners